TNF microsatellite a2, b3 and d2 alleles are associated with systemic lupus erythematosus

Tissue Antigens

Volumn 49, Issue 3 I, 1997, Pages 222-227

  Hajeer, A H ^a   Worthington, J ^a   Davies, E J ^a   Hillarby, M C ^a   Poulton, K ^a   Ollier, W E R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

HLA; Polymorphism; SLE; TNF microsatellite

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; MICROSATELLITE DNA; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; PHOTOSENSITIVITY; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030984576     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02742.x     Document Type: Article

References (32)

1. Deapen D, Escalante A, Weinrib L et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992: 35: 311-18.
2. Winchester RJ, Nunez Roldan A. Some genetic aspects of systemic lupus erythematosus. Arthritis Rheum 1982: 25: 833-7.
3. Arnett FC, Reveille JD. Genetics of systemic lupus erythematosus. Rheum Dis Clin North Am 1992: 18: 865-92.
4. Fielder AHL, Walport MJ, Batchelor R et al. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J 1983: 286: 425-8.
5. Goldstein R, Sengar DP. Comparative studies of the major histocompatibility complex in French Canadian and non-French Canadian Cauacasians with systemic lupus erythematosus. Arthritis Rheum 1993: 36: 1121-7.
6. Briggs DC, Senaldi G, Isenberg DA, Welsh KI, Vergani D. Influence of C4 null alleles on C4 activation in systemic lupus erthymatosus. Ann Rheum Dis 1991: 50: 251-4.
7. Nedospasov SA, Shakhov AN, Turetskaya RL. Tandem arrangement of genes coding for tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) in the human genome. Cold Spring Harb Symp Quant Biol 1986: 51: 611-24.
8. Endres S, Ghorbani R, Lonnemann G, van der Meer JW, Dinarello CA. Measurement of immunoreactive interleukin-1 beta from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor. Clin Immunol Immunopathol 1988: 49: 424-38.
9. Mölvig J, Baek L, Christensen P et al. Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. Scand J Immunol 1988: 27: 705-16.
10. Bendtzen K, Morling N, Fomsgaard A et al. Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol 1988: 28: 599-606.
11. Jacob CO, Fronek Z, Lewis GD, et al. Heritable major histocompatibility complex class Il-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A 1990: 87: 1233-7.
12. Webb GC, Chaplin DD. Genetic variability at the human tumor necrosis factor loci. J Immunol 1990: 145: 1278-85.
13. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1. B8, and DR3 alleles. J Exp Med 1993: 177: 557-60.
14. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNF alpha promoter region. Immunogenetics 1994: 39: 150-154.
15. Fugger L, Morling N, Ryder LP et al. NcoI restriction fragment length polymorphism (RFLP) of the tumour necrosis factor (TNFalpha) region in primary biliary cirrhosis and in healthy Danes. Scand J Immunol 1989: 30: 185-189
16. Tomita Y, Hashimoto S, Yamagami K, Sawada S, Horie T. Restriction fragment length polymorphism (RFLP) analysis in the TNF genes of patients with systemic lupus erythematosus (SLE). Clin Exp Rheumatol 1993: 11: 533-6.
17. Wilson AG, Gordon C, di Giovine FS et al. A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 1994: 24: 91.
18. Fugger L, Morling N, Ryder LP et al. NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases. Tissue Antigens 1989: 34: 17-22.
19. Udalova IA, Nedospasov SA, Webb GC et al. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993: 16: 180-6.
20. Hajeer AH, Worthington J, Silman AJ et al. TNF microsatellite polymorphisms are associated with HLA-DRB1*04 bearing haplotypes in rheumatoid arthritis patients. Arthritis Rheum 1996: 39: 1109-14.
21. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982: 25: 1271-7.
22. Davies EJ, Hillarby MC, Cooper RG et al. HLA-DQ, DR and complement C4 variants in systemic lupus erythematosus. Br J Rheum 1993: 32: 870-5.
23. Davies EJ, Steers G, Ollier WER et al. Relative contributions of HLA-DQA and complement C4A loci in determining susceptibility to systemic lupus erythematosus. Br J Rheum 1995: 34: 221-25.
24. Mills JA. Systemic lupus erythematosus. N Engl J Med 1994: 26: 1871-79.
25. Ollier W, Davies E, Snowden N et al. Homozygosity for glutathione S-transferase GSTM1 null alleles is associated with the Ro+ve/La-ve autoantibody profile in SLE. Arthritis Rheum 1996: 39: 1763-4.
26. Salmon JE, Millard S, Schachter L et al. FcγRII alleles are heritable risk factors for lupus nephritis in African-Americans. Arthritis Rheum (abstract) 1995: 38: S398.
27. Hernández-Caselles T, Stutman O. Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation. J Immunol 1993: 151: 3999-4012.
28. Emlen W, Niebur J-A, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994: 152: 3685-92.
29. Wilson AG, Symons JA, McDowell TL et al. Effects of a tumour necrosis factor (TNF-α) promoter base transition on transcriptional activity. Br J Rheumtol 1994: 33(suppl): 89 (abstract).
30. McGuire W, Hill AVS, Allsopp EM et al. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994: 371: 508-11.
31. Pociot F, Briant L, Jongeneel CV et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex allels with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes melllitus. Eur J Immunol 1993 23: 224-231.
32. Hamilton RG, Harley JB, Bias WB et al. Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus: correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum 1988: 31: 496-505.